First New York Securities’s Cel-Sci Corp Series S CVM.WS Stock Holding History

First New York Securities’s Portfolio CVM.WS Stock Details CVM.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-370,000	Closed	-$81.4K	–	590
2014 Q3	$81.4K	Buy	+370,000	New	+$94.3K	0.06%	202
2014 Q2	–	Sell	-340,000	Closed	-$144K	–	423
2014 Q1	$144K	Buy	+340,000	New	+$141K	0.07%	180

Other funds holding CVM.WS

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

First New York Securities's CVM.WS Position: Q4 2014 in Review

First New York Securities sold out of Cel-Sci Corp Series S (CVM.WS) in Q4 2014, closing a stake of 370,000 shares — an estimated $81.4K sold.

First New York Securities first reported a position in CVM.WS in Q1 2014 and held it in 2 quarters. The position peaked at $144K in Q1 2014. 8 funds tracked by Wall St. Rank hold CVM.WS as of Q4 2014.

First New York Securities reported no remaining Cel-Sci Corp Series S position as of Q4 2014 after selling out during the quarter.
First New York Securities sold 370,000 Cel-Sci Corp Series S shares in Q4 2014, an estimated $81.4K.
First New York Securities first reported a position in Cel-Sci Corp Series S in Q1 2014 and held it in 2 quarters.
First New York Securities's Cel-Sci Corp Series S position peaked at $144K in Q1 2014.
8 funds tracked by Wall St. Rank held Cel-Sci Corp Series S as of Q4 2014.

Based on First New York Securities's 13F filing for Q4 2014, filed 9 Jan 2015.